Skip to main content
. 2012 Feb 3;7:57–71. doi: 10.2147/COPD.S27320

Figure 6.

Figure 6

Time to first moderate or severe exacerbation over the 26-week treatment period.

Notes: *P < 0.001 versus placebo; P = 0.027 versus placebo; P = 0.003 versus placebo.

Abbreviations: F, formoterol; MF, mometasone furoate; MF/F, mometasone furoate/formoterol fixed-dose combination formulation.